These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

602 related articles for article (PubMed ID: 20625573)

  • 61. Pratical aspects of testosterone substitution.
    Wang C; Swerdloff RS
    J Endocrinol Invest; 2005; 28(3 Suppl):109-11. PubMed ID: 16042368
    [TBL] [Abstract][Full Text] [Related]  

  • 62. [Hormone replacement Up-to-date. LOH and testosterone replacement therapy: clinical application].
    Yasuda M
    Clin Calcium; 2007 Sep; 17(9):1326-33. PubMed ID: 17767020
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Testosterone replacement therapy improves health-related quality of life for patients with late-onset hypogonadism: a meta-analysis of randomized controlled trials.
    Nian Y; Ding M; Hu S; He H; Cheng S; Yi L; Li Y; Wang Y
    Andrologia; 2017 May; 49(4):. PubMed ID: 27389320
    [TBL] [Abstract][Full Text] [Related]  

  • 64. The evolving role of testosterone in the treatment of erectile dysfunction.
    Shabsigh R; Rajfer J; Aversa A; Traish AM; Yassin A; Kalinchenko SY; Buvat J
    Int J Clin Pract; 2006 Sep; 60(9):1087-92. PubMed ID: 16939550
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Testosterone deficiency and treatment in older men: definition, treatment, pitfalls.
    Zitzmann M
    Asian J Androl; 2010 Sep; 12(5):623-5. PubMed ID: 20729868
    [No Abstract]   [Full Text] [Related]  

  • 66. Testosterone replacement therapy for late-onset hypogonadism: current trends in Korea.
    Ko YH; Kim JJ
    Asian J Androl; 2011 Jul; 13(4):563-8. PubMed ID: 21572448
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Testim 1% testosterone gel for the treatment of male hypogonadism.
    Bouloux P
    Clin Ther; 2005 Mar; 27(3):286-98. PubMed ID: 15878382
    [TBL] [Abstract][Full Text] [Related]  

  • 68. [LOH (late-onset hypogonadism].
    Itoh N; Hisasue S; Tsukamoto T
    Nihon Rinsho; 2006 Apr; 64 Suppl 4():499-503. PubMed ID: 16689357
    [No Abstract]   [Full Text] [Related]  

  • 69. Opioid-induced hypogonadism: why and how to treat it.
    De Maddalena C; Bellini M; Berra M; Meriggiola MC; Aloisi AM
    Pain Physician; 2012 Jul; 15(3 Suppl):ES111-8. PubMed ID: 22786450
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Testosterone deficiency in men: whom to evaluate, what to measure, and how to treat.
    Miranda JJ; Laufgraben MJ
    Med Health R I; 2011 Mar; 94(3):69-70, 73. PubMed ID: 21488528
    [No Abstract]   [Full Text] [Related]  

  • 71. Symptom report and treatment experience of hypogonadal men with and without type 2 diabetes in a United States health plan.
    Shortridge EF; Polzer P; Donga P; Wade RL
    Int J Clin Pract; 2015 Jul; 69(7):783-90. PubMed ID: 25854747
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Assessment and management of male androgen disorders: an update.
    Chan I; Fui MN; Zajac JD; Grossmann M
    Aust Fam Physician; 2014 May; 43(5):277-82. PubMed ID: 24791767
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Current topics in testosterone replacement of hypogonadal men.
    Nieschlag E
    Best Pract Res Clin Endocrinol Metab; 2015 Jan; 29(1):77-90. PubMed ID: 25617174
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Re: Christina Wang, Eberhard Nieschlag, Ronald Swerdloff, et al. Investigation, treatment, and monitoring of late-onset hypogonadism in males: ISA, ISSAM, EAU, EAA, and ASA recommendations. Eur Urol 2009;55:121-30.
    Ponholzer A; Madersbacher S
    Eur Urol; 2009 May; 55(5):e92; author reply e93-4. PubMed ID: 19081175
    [No Abstract]   [Full Text] [Related]  

  • 75. How to help the aging male? Current approaches to hypogonadism in primary care.
    Lunenfeld B; Arver S; Moncada I; Rees DA; Schulte HM
    Aging Male; 2012 Dec; 15(4):187-97. PubMed ID: 23067307
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Bone benefits of testosterone replacement therapy in male hypogonadism.
    Tirabassi G; Biagioli A; Balercia G
    Panminerva Med; 2014 Jun; 56(2):151-63. PubMed ID: 24994579
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Testosterone therapy improves the clinical response to conventional treatment for male patients with metabolic syndrome associated to late onset hypogonadism.
    La Vignera S; Calogero AE; D'Agata R; Di Mauro M; Tumino S; Condorelli R; Lanzafame F; Finocchiaro C; Giammusso B; Vicari E
    Minerva Endocrinol; 2008 Sep; 33(3):159-67. PubMed ID: 18846023
    [TBL] [Abstract][Full Text] [Related]  

  • 78. The aging male: androgens, erectile dysfunction, and depression.
    Seidman SN
    J Clin Psychiatry; 2003; 64 Suppl 10():31-7. PubMed ID: 12971814
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Testosterone replacement therapy by testosterone ointment relieves lower urinary tract symptoms in late onset hypogonadism patients.
    Amano T; Imao T; Takemae K; Iwamoto T; Nakanome M
    Aging Male; 2010 Dec; 13(4):242-6. PubMed ID: 20795793
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Testosterone treatment in the aging male: myth or reality?
    Nigro N; Christ-Crain M
    Swiss Med Wkly; 2012; 142():w13539. PubMed ID: 22430839
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 31.